title: A nonradioisotope chemiluminescent assay for evaluation of 2-deoxyglucose uptake in 3T3-L1 adipocytes. Effect of various carbonyls species on insulin action.
abstract: We have developed a rapid nonradioisotope chemiluminescent assay adapted to high-throughput screening experiments, to evaluate glucose uptake activity in cultured cells. For chemiluminescence quantification of 2-deoxyglucose, we used a luminol oxidation reaction after an enzymatic dephosphorylation of 2-deoxyglucose-6-phosphate. All reactions were performed at 37 °C by consecutive addition of reagents, and the assay is able to quantify 2DG in picomole per well. To confirm the reliability of this method, we have evaluated the dose-effect of insulin, GLUT4 inhibitors and insulin-sensitizing agent on 2DG uptake into 3T3-L1 cells. The results obtained with the assay for 2DG uptake in vitro in the absence or presence of insulin stimulation, were similar to those obtained by the previous radioisotopic and enzymatic methods. We have also used this assay to evaluate the effect of various reactive carbonyl and oxygen species on insulin-stimulated 2DG-uptake into adipocytes. All reactive carbonyl species tested decreased insulin-stimulated glucose uptake in a time- and dose-dependent manner without affecting basal glucose uptake in 3T3-L1 cells. 4-hydroxynonenal was found to be the most potent in the impairment of glucose uptake. This new enzymatic chemiluminescent assay is rapid and useful for measurement of 2DG uptake in insulin-responsive in cultured cells.
authors: Aix Marseille Université, Faculté des Sciences de St Jérôme, Institut de chimie radicalaire, UMR-7273 CNRS, 13397 Marseille Cedex 20, France.
authors: Nicolas
authors: N
authors: Vidal
authors: Jean Pierre
authors: JP
authors: Cavaillé
authors: Marjorie
authors: M
authors: Poggi
authors: Franck
authors: F
authors: Peiretti
authors: Pierre
authors: P
authors: Stocker
mesh_terms: D041721:3T3-L1 Cells; D000171:Acrolein / Q000494:pharmacology; D017667:Adipocytes / Q000187:drug effects* / Q000378:metabolism*; D000447:Aldehydes / Q000494:pharmacology; D000818:Animals; D001692:Biological Transport / Q000187:drug effects; D002839:Chromans / Q000494:pharmacology; D003571:Cytochalasin B / Q000494:pharmacology; D003847:Deoxyglucose / Q000378:metabolism / Q000493:pharmacokinetics*; D006861:Hydrogen Peroxide / Q000494:pharmacology; D007004:Hypoglycemic Agents / Q000494:pharmacology; D007328:Insulin / Q000494:pharmacology; D008163:Luminescent Measurements / Q000295:instrumentation / Q000379:methods*; D051379:Mice; D011765:Pyruvaldehyde / Q000494:pharmacology; D015203:Reproducibility of Results; D045162:Thiazolidinediones / Q000494:pharmacology; D000077288:Troglitazone
chemical_list: D000447:Aldehydes; D002839:Chromans; D007004:Hypoglycemic Agents; D007328:Insulin; D045162:Thiazolidinediones; D003571:Cytochalasin B; D011765:Pyruvaldehyde; D000171:Acrolein; D003847:Deoxyglucose; D006861:Hydrogen Peroxide; D000077288:Troglitazone; C027576:4-hydroxy-2-nonenal